SAGE THERAPEUTICS, INC.

(SAGE)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
42.99 USD   +2.41%
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Rating
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart SAGE THERAPEUTICS, INC.
Upcoming events on SAGE THERAPEUTICS, INC.
11/02/22 Q3 2022 Earnings Release (Projected)
02/23/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
08/01/23 Interim 2023 Earnings Release (Projected)
Past events on SAGE THERAPEUTICS, INC.
08/10/22 | 10:00am Canaccord Growth Conference - Fireside Chat
08/09/22 | 09:00am Wedbush PacGrow Healthcare Conference - Fireside Chat
08/02/22 | 08:00am Interim 2022 Earnings Call
08/02/22 | 06:30am Interim 2022 Earnings Release
06/16/22 | 09:00am Annual General Meeting
06/13/22 | 06:20pm Goldman Sachs Global Healthcare Conference
06/08/22 | 11:30am Jefferies Healthcare Conference
06/01/22 | 08:00am Zuranolone Phase 3 SKYLARK Study Results Call
05/11/22 | 11:00am Bank of America Healthcare Conference
05/03/22 | 08:00am Q1 2022 Earnings Call
Past dividends on SAGE THERAPEUTICS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread


 
90,3
90,0
0,30%
6,87
8,72
-21%
1 114
7,04
15 717%
6,31
6,48
-2,6%
 
6,93
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-273
-285
4,4%
-392
-375
-4,5%
-706
-736
4,0%
627
-479
231%
-457
-456
-0,07%
 
-524
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-273
-282
3,2%
-393
-369
-6,6%
-708
-728
2,8%
624
-483
229%
-461
-463
0,43%
 
-524
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-270
-279
3,0%
-373
-347
-7,4%
-680
-701
2,9%
606
-471
229%
-458
-457
-0,11%
 
-517
 
Net income
M $
Released
Forecast
Spread
-270
-279
3,3%
-373
-349
-6,8%
-680
-700
2,9%
606
-473
228%
-458
-459
0,25%
 
-519
 
EPS
$
Released
Forecast
Spread
-7,09
-7,38
3,9%
-8,08
-7,54
-7,1%
-13,4
-13,8
2,7%
11,4
-9,07
226%
-7,80
-7,82
0,28%
 
-8,70
 
Announcement Date02/22/201802/19/201902/27/202002/24/202102/24/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
1,64
2,01
-18%
1,44
1,97
-27%
1,64
1,77
-7,3%
1,58
3,23
-51%
1,50
1,77
-15%
 
1,70
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-107
-92,6
-16%
-131
-106
-23%
-125
-123
-1,9%
-119
-135
12%
-126
-134
6,6%
 
-136
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-108
-102
-6,4%
-131
-110
-19%
-125
-129
3,0%
-123
-122
-1,1%
-128
-128
0,02%
 
-132
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-107
-99,2
-8,1%
-130
-109
-20%
-125
-126
1,2%
-122
-121
-1,3%
-126
-127
0,54%
 
-129
 
Net income
M $
Released
Forecast
Spread
-107
-99,1
-8,2%
-130
-108
-20%
-125
-128
2,6%
-122
-121
-1,0%
-126
-127
0,75%
 
-130
 
EPS
$
Released
Forecast
Spread
-1,83
-1,68
-8,9%
-2,21
-1,85
-19%
-2,12
-2,17
2,1%
-2,07
-2,03
-2,1%
-2,13
-2,15
1,0%
 
-2,21
 
Announcement Date08/03/202111/02/202102/24/202205/03/202208/02/2022-
Previous year Next Year
Upcoming sector events for SAGE THERAPEUTICS, INC.
More events
Past sector events for SAGE THERAPEUTICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise